Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soon Thye Lim

Showing results (111-120 of 184) with videos related to

Pageof 19
Sort By:
Blood|August 9, 2020
Avelumab for the treatment of relapsed or refractory extranodal NK/T-cell lymphoma: an open-label phase 2 studySeok Jin Kim, Jing Quan Lim, Yurike Laurensia, et al.
Blood Cancer Journal|August 13, 2021
High-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphomaShin Yeu Ong, Sanjay de Mel, Nicholas Francis Grigoropoulos, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 13, 2018
Assessment of psychological distress among Asian adolescents and young adults (AYA) cancer patients using the distress thermometer: a prospective, longitudinal studyAlexandre Chan, Eileen Poon, Wei Lin Goh, et al.
Leukemia & Lymphoma|October 19, 2021
Prognostication of diffuse large B-cell lymphoma patients with Deauville score of 3 or 4 at end-of-treatment PET evaluation: a comparison of the Deauville 5-point scale and the ΔSUVmax methodDavid Z Ng, Chuan Yaw Lee, Winnie W Lam, et al.
Cancer Medicine|July 3, 2019
Real world experience of R-CHOP with or without consolidative radiotherapy vs DA-EPOCH-R in the first-line treatment of primary mediastinal B-cell lymphomaEsther Hian Li Chan, Liang Piu Koh, Joanne Lee, et al.
Molecular Cancer|April 9, 2023
Super-enhancer-driven TOX2 mediates oncogenesis in Natural Killer/T Cell LymphomaJianbiao Zhou, Sabrina Hui-Min Toh, Tze King Tan, et al.
Medcomm|June 19, 2023
Preclinical characterization of WB737, a potent and selective STAT3 inhibitor, in natural killer/T-cell lymphomaYali Wang, Wenbo Zhou, Jianfeng Chen, et al.
Nature Communications|October 23, 2020
Targeting N-myristoylation for therapy of B-cell lymphomasErwan Beauchamp, Megan C Yap, Aishwarya Iyer, et al.
Molecular and Clinical Oncology|September 10, 2019
Successful therapeutic rechallenge after a severe episode of high dose methotrexate-induced choreoathetosis: A case reportLip Leong Chong, Evelyn Yi Ting Wong, Sheryl Lyn Lucero Santos-Banta, et al.
Blood Advances|October 5, 2020
Whole-genome sequencing reveals potent therapeutic strategy for monomorphic epitheliotropic intestinal T-cell lymphomaDachuan Huang, Jing Quan Lim, Daryl Ming Zhe Cheah, et al.
Pageof 19

Showing results (111-120 of 184) with videos related to

Sort By:
Pageof 19
Blood|August 9, 2020
Avelumab for the treatment of relapsed or refractory extranodal NK/T-cell lymphoma: an open-label phase 2 studySeok Jin Kim, Jing Quan Lim, Yurike Laurensia, et al.
Blood Cancer Journal|August 13, 2021
High-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphomaShin Yeu Ong, Sanjay de Mel, Nicholas Francis Grigoropoulos, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 13, 2018
Assessment of psychological distress among Asian adolescents and young adults (AYA) cancer patients using the distress thermometer: a prospective, longitudinal studyAlexandre Chan, Eileen Poon, Wei Lin Goh, et al.
Leukemia & Lymphoma|October 19, 2021
Prognostication of diffuse large B-cell lymphoma patients with Deauville score of 3 or 4 at end-of-treatment PET evaluation: a comparison of the Deauville 5-point scale and the ΔSUVmax methodDavid Z Ng, Chuan Yaw Lee, Winnie W Lam, et al.
Cancer Medicine|July 3, 2019
Real world experience of R-CHOP with or without consolidative radiotherapy vs DA-EPOCH-R in the first-line treatment of primary mediastinal B-cell lymphomaEsther Hian Li Chan, Liang Piu Koh, Joanne Lee, et al.
Molecular Cancer|April 9, 2023
Super-enhancer-driven TOX2 mediates oncogenesis in Natural Killer/T Cell LymphomaJianbiao Zhou, Sabrina Hui-Min Toh, Tze King Tan, et al.
Medcomm|June 19, 2023
Preclinical characterization of WB737, a potent and selective STAT3 inhibitor, in natural killer/T-cell lymphomaYali Wang, Wenbo Zhou, Jianfeng Chen, et al.
Nature Communications|October 23, 2020
Targeting N-myristoylation for therapy of B-cell lymphomasErwan Beauchamp, Megan C Yap, Aishwarya Iyer, et al.
Molecular and Clinical Oncology|September 10, 2019
Successful therapeutic rechallenge after a severe episode of high dose methotrexate-induced choreoathetosis: A case reportLip Leong Chong, Evelyn Yi Ting Wong, Sheryl Lyn Lucero Santos-Banta, et al.
Blood Advances|October 5, 2020
Whole-genome sequencing reveals potent therapeutic strategy for monomorphic epitheliotropic intestinal T-cell lymphomaDachuan Huang, Jing Quan Lim, Daryl Ming Zhe Cheah, et al.
Pageof 19